Search

  • HOME
  • Search
Original Articles
1918
Primary Sites and Clinicopathological Features of Corneal Melanoma: A Surveillance, Epidemiology, and End Results (SEER) Population-based Study of 29 Cases
Alexander W. Suh, Sowmya Ravi, Kenneth Tran et al.
Korean J Ophthalmol. 2025;39(1):23-30.   Published online December 23, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Biometric Risk Factors for Corneal Neovascularization Associated with Hydrogel Soft Contact Lens Wear in Korean Myopic Patients
Dae Seung Lee, Mee Kum Kim, Won Ryang Wee
Korean J Ophthalmol. 2014;28(4):292-297.   Published online July 22, 2014
Full textFull text    PubreaderPubReader    PDFPDF    
Case Reports
Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
Ye Jin Ahn, Hyung Bin Hwang, Sung Kun Chung
Korean J Ophthalmol. 2014;28(2):177-180.   Published online March 14, 2014
Full textFull text    PubreaderPubReader    PDFPDF    
Original Articles
The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
Jin-Hyoung Kim, Hae-Won Seo, Hyun-Cheol Han, Jong-Hyun Lee, Suk-Kyue Choi, Doh Lee
Korean J Ophthalmol. 2013;27(4):235-242.   Published online July 5, 2013
Full textFull text    PubreaderPubReader    PDFPDF    
Case Report
Treatment of corneal neovascularization with argon laser.
Kyung Jik Lim, Won Ryang Wee, Jin Hak Lee
Korean J Ophthalmol. 1993;7(1):25-27.   Published online June 30, 1993
PDFPDF    

Korean Journal of
Ophthalmology

Print ISSN: 1011-8942
Online ISSN: 2092-9382



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6788    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2025 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next